FIELD: chemistry.
SUBSTANCE: invention relates to compounds of formula VII, where the values W, Y, L, n are defined in the claims.
EFFECT: compounds are useful in the treatment of MCT4 mediated diseases such as proliferative and inflammatory diseases.
12 cl, 30 tbl, 269 ex
Title | Year | Author | Number |
---|---|---|---|
SERIN / TREONIN KINASE INHIBITORS FOR TREATING OF HYPEROPLIFERATIVE DISEASES | 2013 |
|
RU2644947C2 |
SUBSTITUTED HETEROCYCLIC SULPHONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS | 2014 |
|
RU2675792C2 |
OXADIAZOLE-BASED CHANNEL INHIBITORS WITH TRANSIENT POTENTIAL | 2019 |
|
RU2818244C2 |
BICYCLIC DERIVATIVES, METHODS FOR THEIR PREPARING, PHARMACEUTICAL COMPOSITION CONTAINING THEREOF, THEIR USING IN TREATMENT AND METHOD FOR TREATMENT OF MAMMALS BY THEIR USING | 2002 |
|
RU2310655C2 |
SUBSTITUTED PYRIDINE AND PYRAZINE COMPOUNDS AS PDE4 INHIBITORS | 2014 |
|
RU2668073C2 |
PYRIDOPYRIMIDINONE DERIVATIVES AND USE THEREOF AS AROMATIC HYDROCARBON RECEPTOR MODULATORS | 2021 |
|
RU2818954C1 |
INHIBITORS OF CYTOSOLIC PHOSPHOLIPASE A2 | 2002 |
|
RU2337906C2 |
HETEROARYL COMPOUNDS AS IRAK INHIBITORS AND USE THEREOF | 2016 |
|
RU2743360C2 |
BRUTON'S TYROSINE KINASE INHIBITORS | 2013 |
|
RU2619465C2 |
BICYCLIC UREA, THIOUREA, GUANIDINE AND CYANOHUANIDINE COMPOUNDS, USEFUL FOR THE TREATMENT OF PAIN | 2013 |
|
RU2664541C2 |
Authors
Dates
2022-05-13—Published
2017-12-12—Filed